| PUBLICATIONS (Ranked by impact factor of the journal) | LABORATORY RESEARCH Nuclear Kaiso Indicates Aggressive Prostate Cancers and Promotes Migration and Invasiveness of Prostate Cancer Cells Researchers found an enrichment of nuclear Kaiso expression in cells of primary and metastatic prostate tumors relative to the normal prostate epithelium. In both DU-145 and PC-3 prostate cancer cell lines, Kaiso inhibition decreased cell migration and invasion, even in the presence of epidermal growth factor. [Am J Pathol] Abstract Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer Scientists identified a novel and pivotal role for extracellular Hsp90 (eHsp90) in driving EMT events in prostate cancer. They demonstrated that eHsp90 promoted cell motility in an ERK and matrix metalloproteinases (MMP)- 2/9-dependent manner, and shifted cellular morphology towards a mesenchymal phenotype. [J Biol Chem] Full Article Enhancing the Effectiveness of Androgen Deprivation in Prostate Cancer by Inducing Filamin A Nuclear Localization The authors showed that Filamin A nuclear localization induced apoptosis in castration-resistant prostate cancer cells during androgen deprivation therapy, identifying it as a treatment tool in advanced prostate cancer. [Endocr Relat Cancer] Abstract In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer Recent evidence indicates that xenotropic murine leukemia virus-related virus (XMRV) is a contaminant originating from the recombination of two mouse endogenous retroviruses during passaging of a prostate tumor xenograft in mice, generating laboratory-derived cell lines that are XMRV-infected. To confirm or refute an association between XMRV and prostate cancer, investigators analyzed prostate cancer tissues and plasma from a prospectively collected cohort of 39 patients as well as archival RNA and prostate tissue. [PLoS One] Full Article | Press Release 7-Epi-Nemorosone from Clusia rosea Induces Apoptosis, Androgen Receptor Down-Regulation and Dysregulation of Prostate Specific Antigen Levels in LNCaP Prostate Carcinoma Cells Scientists aimed to characterize the antitumoral activity of the plant compound 7-epi-nemorosone in prostate carcinoma cell lines. They demonstrated that 7-epi-nemorosone exerts cytotoxicity in an androgen-dependent prostate carcinoma entity by targeting the MEK1/2 signal transducer. [Phytomedicine] Abstract Simultaneous Modulation of the Intrinsic and Extrinsic Pathways by Simvastatin in Mediating Prostate Cancer Cell Apoptosis The molecular mechanisms by which simvastatin induced apoptosis in prostate cancer cells is not completely understood. Researchers studied the effect of simvastatin on PC3 cell apoptosis compared with docetaxel using apoptosis, TUNEL and trypan blue viability assays. [BMC Cancer] Abstract | Full Article TGFβ1 Induces Apoptosis in Invasive Prostate Cancer and Bladder Cancer Cells via Akt-Independent, p38 MAPK and JNK/SAPK-Mediated Activation of Caspases The authors investigated the effect of transforming growth factor-β1 (TGFβ) on the survival and proliferation of invasive prostate (PC3) and bladder (T24) cancer cells. Their study indicated that TGFβ1 decreased cell viability and induced apoptosis in invasive human PC3 and T24 cells via activation of p38 mitogen activated protein kinase (p38 MAPK)-c-jun N-terminal kinase (JNK)-Caspase9/8/3 pathway. [Biochem Biophy Res Commun] Abstract Ethanol Promotes Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand through Induction of Reactive Oxygen Species in Prostate Cancer Cells Scientists demonstrated that ethanol enhances the apoptosis-inducing potential of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in androgen-resistant PC3 cells and sensitizes TRAIL-resistant, androgen sensitive LNCaP cells to apoptosis through caspase activation, and a complete cleavage of poly-ribose polymerase, which was in association with increased production of reactive oxygen species. [Prostate Cancer Prostatic Dis] Abstract Differential Molecular Mechanism of Docetaxel-Octreotide Combined Treatment According to the Docetaxel-Resistance Status in PC3 Prostate Cancer Cells Investigators examined the effect and the molecular mechanisms of the combined treatment of the somatostatin analogue octreotide with docetaxel through analysis of proliferation, apoptosis and migration in the human prostate cancer cell line PC3, either sensitive or made resistant to docetaxel. [Anticancer Drugs] Abstract CLINICAL RESEARCH Abiraterone Acetate for Treatment of Metastatic Castration-Resistant Prostate Cancer: Final Overall Survival Analysis of a Randomized, Double-Blind, Placebo-Controlled Phase III Study Abiraterone acetate improved overall survival in metastatic castration-resistant prostate cancer at a preplanned interim analysis of the COU-AA-301 double-blind, placebo-controlled phase III study. Scientists presented the final analysis of the study before crossover from placebo to abiraterone acetate. [Lancet Oncol] Abstract Targeting p53 In Vivo: A First-in-Human Study with p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer Researchers aimed to determine maximum-tolerated dose, safety, dose-limiting toxicities, and pharmacokinetics of APR-246. APR-246 was administered as a two-hour intravenous infusion once per day for four consecutive days in 22 patients with hematologic malignancies and prostate cancer. [J Clin Oncol] Abstract | Press Release
|
|
|
|